Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125633442 | 12563344 | 2 | F | 20160705 | 20160826 | 20160715 | 20160829 | EXP | AU-ABBVIE-16P-008-1616386-00 | ABBVIE | 71.36 | YR | M | Y | 130.00000 | KG | 20160829 | OT | COUNTRY NOT SPECIFIED | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125633442 | 12563344 | 1 | PS | VIEKIRA PAK | DASABUVIROMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | 2 12.5/75/50MG: DASABUVIR 250MG | Y | UNKNOWN | 206619 | TABLET | BID | ||||||
| 125633442 | 12563344 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | UNKNOWN | 0 | 200 | MG | TABLET | BID | |||||
| 125633442 | 12563344 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | UNKNOWN | 0 | 200 | MG | TABLET | QD | |||||
| 125633442 | 12563344 | 4 | C | LACTULOSE. | LACTULOSE | 1 | Oral | 0 | 20 | ML | BID | ||||||||
| 125633442 | 12563344 | 5 | C | EZETIMIBE. | EZETIMIBE | 1 | Oral | IN THE MORNING AND AT NIGHT | 0 | 10 | MG | BID | |||||||
| 125633442 | 12563344 | 6 | C | GLICLAZIDE | GLICLAZIDE | 1 | Oral | 0 | 30 | MG | |||||||||
| 125633442 | 12563344 | 7 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 125633442 | 12563344 | 8 | C | PROPANOLOL | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | BID | ||||||||
| 125633442 | 12563344 | 9 | C | RANITIDINE. | RANITIDINE | 1 | Oral | 0 | 30 | MG | QD | ||||||||
| 125633442 | 12563344 | 10 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 200 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125633442 | 12563344 | 1 | Hepatitis C |
| 125633442 | 12563344 | 2 | Hepatitis C |
| 125633442 | 12563344 | 4 | Constipation |
| 125633442 | 12563344 | 5 | Type 2 diabetes mellitus |
| 125633442 | 12563344 | 6 | Type 2 diabetes mellitus |
| 125633442 | 12563344 | 7 | Gastrooesophageal reflux disease |
| 125633442 | 12563344 | 8 | Varicose vein |
| 125633442 | 12563344 | 9 | Gastrooesophageal reflux disease |
| 125633442 | 12563344 | 10 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125633442 | 12563344 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125633442 | 12563344 | Constipation | |
| 125633442 | 12563344 | Diarrhoea | |
| 125633442 | 12563344 | Haemoglobin decreased | |
| 125633442 | 12563344 | Hepatic encephalopathy | |
| 125633442 | 12563344 | Infection | |
| 125633442 | 12563344 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125633442 | 12563344 | 1 | 20160125 | 20160706 | 0 | |
| 125633442 | 12563344 | 2 | 20160122 | 0 | ||
| 125633442 | 12563344 | 3 | 20160706 | 0 |